Article
Clinical Outcomes of Epidermal Growth Factor Receptor (EGFR) Mutated Metastatic Non-Small Cell Lung Cancer in Kurdistan Region: A Retrospective Study
2026-08-20
Abstract excerpt
<title>Abstract</title> <p>Background Lung cancer in general is one the leading cause of cancer-related mortality worldwide. It’s broadly classified into small cell lung carcinoma and non-small cell lung carcinoma (NSCLC), the latter accounting for 80% of cases. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) have transformed NSCLC management. This study aims to evaluate the clinical out...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5cfdeed6-aef7-57fd-87f1-5e168a1e1e2e
- DOI
- 10.21203/rs.3.rs-10035710/v1
